本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aktis Oncology

25.98
+1.917.94%
盤後26.350.3700+1.42%19:30 EDT
成交量:77.46萬
成交額:1,941.98萬
市值:14.36億
市盈率:-21.41
高:26.31
開:24.15
低:22.96
收:24.07
52周最高:34.19
52周最低:14.72
股本:5,527.60萬
流通股本:1,765.00萬
量比:3.71
換手率:4.39%
股息:- -
股息率:- -
每股收益(TTM):-1.2134
每股收益(LYR):-78.3394
淨資產收益率:-29.45%
總資產收益率:-15.79%
市淨率:2.96
市盈率(LYR):-0.33

資料載入中...

2026/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/11

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/01/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/07

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2026/01/05

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/12/19

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/12/18

重要事件披露

Form 8-K - Current report
2024/12/16

重要事件披露

Form 8-K - Current report
2024/12/12

重要事件披露

Form 8-K - Current report